An active murine-human chimeric Fab antibody derived from Escherichia coli, potential therapy against over-expressing VEGFR2 solid tumors.
about
Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric FabA novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity.A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells.
P2860
An active murine-human chimeric Fab antibody derived from Escherichia coli, potential therapy against over-expressing VEGFR2 solid tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
An active murine-human chimeri ...... xpressing VEGFR2 solid tumors.
@en
type
label
An active murine-human chimeri ...... xpressing VEGFR2 solid tumors.
@en
prefLabel
An active murine-human chimeri ...... xpressing VEGFR2 solid tumors.
@en
P2093
P2860
P1476
An active murine-human chimeri ...... xpressing VEGFR2 solid tumors.
@en
P2093
Jianfei Huang
Zhenqing Feng
Zhongchan Wang
P2860
P2888
P304
P356
10.1007/S00253-011-3335-Y
P407
P577
2011-05-22T00:00:00Z
P6179
1018185168